JP2006525367A5 - - Google Patents

Download PDF

Info

Publication number
JP2006525367A5
JP2006525367A5 JP2006514246A JP2006514246A JP2006525367A5 JP 2006525367 A5 JP2006525367 A5 JP 2006525367A5 JP 2006514246 A JP2006514246 A JP 2006514246A JP 2006514246 A JP2006514246 A JP 2006514246A JP 2006525367 A5 JP2006525367 A5 JP 2006525367A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
dihydroxy
compound
vitamin
cholecalciferol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006514246A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006525367A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/013703 external-priority patent/WO2004098522A2/en
Publication of JP2006525367A publication Critical patent/JP2006525367A/ja
Publication of JP2006525367A5 publication Critical patent/JP2006525367A5/ja
Pending legal-status Critical Current

Links

JP2006514246A 2003-04-30 2004-04-30 ジェミニビタミンd3化合物及びその使用方法 Pending JP2006525367A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46663803P 2003-04-30 2003-04-30
PCT/US2004/013703 WO2004098522A2 (en) 2003-04-30 2004-04-30 Gemini vitamin d3 compounds and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2006525367A JP2006525367A (ja) 2006-11-09
JP2006525367A5 true JP2006525367A5 (enExample) 2007-07-05

Family

ID=33434966

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006514246A Pending JP2006525367A (ja) 2003-04-30 2004-04-30 ジェミニビタミンd3化合物及びその使用方法

Country Status (5)

Country Link
EP (1) EP1622455A4 (enExample)
JP (1) JP2006525367A (enExample)
AU (1) AU2004235775A1 (enExample)
CA (1) CA2524026A1 (enExample)
WO (1) WO2004098522A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050192255A1 (en) * 2003-07-30 2005-09-01 Jin Tian Use of Vitamin Ds or Vitamin D analogs to treat cardiovascular disease
CA2540325A1 (en) * 2003-09-24 2005-04-07 Bioxell Spa Methods for treating bladder dysfunction
JP2008521935A (ja) * 2004-12-02 2008-06-26 アボット・ラボラトリーズ 哺乳動物において、内膜過形成、平滑筋細胞増殖及び再狭窄を軽減するための、ビタミンd受容体を活性化する化合物の使用
WO2006117684A1 (en) * 2005-03-23 2006-11-09 Bioxell S.P.A. Methods of treating osteoporosis and secondary hyperparathyroidism using 20-methyl, gemini vitamin d3 compounds
EP1879596A4 (en) * 2005-03-23 2009-01-21 Bioxell Spa 20 ALKYL, GEMINI VITAMIN D3 COMPOUNDS AND METHOD OF USE THEREOF
US7286295B1 (en) 2005-11-30 2007-10-23 Sandia Corporation Microoptical compound lens
US20100093675A1 (en) * 2006-09-22 2010-04-15 Bioxell S.P.A. Novel method
FI3225243T3 (fi) * 2007-04-25 2025-10-13 Opko Renal Llc Menetelmä sekundaarisen hyperparatyreoosin turvalliseen ja tehokkaaseen hoitoon ja ehkäisyyn kroonisen munuaistaudin yhteydessä
US20110274743A1 (en) * 2009-01-16 2011-11-10 Pharmaceutical Compounding Nz Limited Medicament for the Treatment of Pain and Inflammation
CN104758300A (zh) * 2014-01-02 2015-07-08 上海泽生科技开发有限公司 维生素d及其组合物的抗菌用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008209A (en) * 1997-04-28 1999-12-28 Hoffmann-La Roche Inc. Method of using vitamin D3 analogs with bis C-20 side chains
US6030962A (en) * 1997-04-28 2000-02-29 Synttex (U.S.A.) Inc. Vitamin D3 analogs with bis C-20 side chains
PT980354E (pt) * 1997-04-28 2002-10-31 Hoffmann La Roche Analogos de vitamina d3 com cadeias laterais bis-c-20
AU744471B2 (en) * 1997-05-16 2002-02-21 Women & Infants Hospital 3-epi vitamin D2 compounds and uses thereof
US6331642B1 (en) * 1999-07-12 2001-12-18 Hoffmann-La Roche Inc. Vitamin D3 analogs
US20030095937A1 (en) * 2001-10-02 2003-05-22 Koeffler H. Philip Method for stimulating hair growth by administering vitamin D analogs

Similar Documents

Publication Publication Date Title
JP2007506765A5 (enExample)
JP2006525367A5 (enExample)
JP2007525494A5 (enExample)
JP2009525981A5 (enExample)
CA2676670A1 (en) Tricyclic compounds, compositions, and methods
JP2016505019A5 (enExample)
US20180230102A1 (en) Carboxy substituted (hetero) aromatic ring derivatives and preparation method and uses thereof
JP2008514621A5 (enExample)
ITMI981744A1 (it) Sali nitrati di farmaci
EP1355876A1 (en) Methods of chemical synthesis of phenolic nitrogen mustard prodrugs
JP2007504128A5 (enExample)
HUP0002839A2 (hu) Pirrolo[3,4-d]pirimidinon-származékok, alkalmazásuk, az ezeket tartalmazó gyógyszerkészítmények, eljárás előállításukra
JP2008538114A5 (enExample)
KR102856998B1 (ko) Jak 키나아제 관련 질병의 치료를 위한 약물의 제조에 있어서 jak 억제제의 용도
RU2564414C2 (ru) Новый агонист ер4
WO2009081208A1 (en) Processes to pregabalin
JP5744003B2 (ja) 抗ウイルス化合物を調製する方法
SA518392275B1 (ar) -2h-مشتق 5- ميثيل -6- فينيل -4، 5- داي هيدرو بيريدازين -3- أون
JP2008520709A5 (enExample)
WO2006129688A1 (ja) 2-アミノブタノール化合物及びその医薬用途
JPS6158449B2 (enExample)
JP2009143931A (ja) テトラゾリルベンゾピランの製法
NZ570711A (en) 2-Substituted-1alpha, 25-dihydroxy-19,26,27-trinor vitamin D analogs and uses thereof
Kim et al. Synthesis and anti‐HIV‐1 activity of a series of 1‐(alkoxymethyl)‐5‐alkyl‐6‐(arylselenenyl) uracils and‐2‐thiouracils
CA2448518A1 (en) New compounds useful in reflux disease